MedPath

Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: AcrySof Toric intraocular lens, model SN60TT
Device: AcrySof Monofocal IOL, model SN60AT
Registration Number
NCT01075542
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The purpose of this study is to determine if Toric intraocular lens implantation in cataract surgery is a more efficient and cost-effective treatment of astigmatism than Monofocal intraocular lens implantation.

Detailed Description

A recent innovation in cataract surgery consists of the introduction of toric intraocular lenses (IOLs) that can correct corneal astigmatism. It offers the opportunity for patients with substantial astigmatism to achieve optimal distance vision without using spectacles. Good near vision may subsequently be achieved with low-cost reading glasses. The current practice of non-toric IOL implantation in astigmatic patients warrants the use of expensive bifocal or multifocal spectacles with cylinder correction to achieve good distance and near vision.

Objective: The primary objective of this study is to compare spectacle independence for distance vision following toric IOL implantation and monofocal intraocular lens (IOL) implantation. The secondary objectives are to compare uncorrected distance vision, residual refractive astigmatism, quality of vision, wavefront aberrations, contrast sensitivity, complication profile, costs of postoperative spectacles and cost-effectiveness.

Study design: Multi-centre randomised clinical trial. Study population: 160 patients with regular corneal astigmatism of at least 1.25 diopters in both eyes who require bilateral cataract surgery.

Intervention: Cataract surgery with implantation of a toric IOL (AcrySof model SN60TT) or an monofocal IOL (AcrySof model SN60AT).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Bilateral cataract
  • Bilateral corneal astigmatism (at least 1.25D)
  • Predicted residual astigmatism less than 0.5D
Exclusion Criteria
  • Irregular corneal astigmatism or keratoconus
  • Fuchs endothelial dystrophy (stage 2)
  • Expected postoperative best-corrected visual acuity worse than logMAR +0.3

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Toric intraocular lensAcrySof Toric intraocular lens, model SN60TTBilateral Toric intraocular lens implantation in cataract surgery
Monofocal intraocular lensAcrySof Monofocal IOL, model SN60ATBilateral Monofocal intraocular lens implantation in cataract surgery
Primary Outcome Measures
NameTimeMethod
Spectacle independencypreop, 3 months and 6 months postop

Spectacle independency for distance vision

Secondary Outcome Measures
NameTimeMethod
Costs related to interventionpreop, 3 and 6 months postop

Total cost-analysis, including out-of-hospital costs for patient

Visual acuitypreop, 1 day, 1 month, 3 months and 6 months postop
Higher-order wavefront aberrationspreop, 3 months and 6 months postop
Contrast sensitivitypreop, 3 months and 6 months postop
Refractive astigmatismpreop, 3 months and 6 months postop
Quality of visionpreop, 3 months, 6 months

Refractive-error related quality of vision

Trial Locations

Locations (3)

Atrium Medical Center

🇳🇱

Heerlen, Brunssum, Kerkrade, Netherlands

Maastricht University Medical Center

🇳🇱

Maastricht, Netherlands

Rotterdam Eye Hospital

🇳🇱

Rotterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath